application) Eligibility: The research supported by the Pilot and Feasibility Studies Program is primarily intended to be a first grant for junior faculty at the U Washington who have not yet obtained a major peer-reviewed grant (such as an R01 or K21) in the areas of diabetes or endocrinology. Senior faculty members are also eligible to apply if their projects represent first entry into the field of diabetes research. Established investigators in diabetes are also eligible if their purpose is to test innovative ideas that truly represent a clear departure from previous research activity. Any single investigator is eligible to receive a P and F award only once, unless the second P and F is a clear departure from the research area of the original award. Funding level: Since NIH funding to our DERC P and F Studies Program has been $50,000 per year for all P and F projects combined, up to now there has been limited support for each project to a maximum of $25,000 yearly. Awards are made initially for one year, but a second year?s funding is provided if satisfactory progress is made during the first year. Despite these limited funds, there has been a large response to calls for applications and numerous meritorious research projects have been supported. As a result of increased funding to the Diabetes Center for P and F studies, an increase in the funding level and the number of awards in the P and F program is proposed. It is intended that $200,000 of the new DERC budget be allocated to P and F research awards. Recipients must be members of the U. Washington faculty (postdoctoral fellows and research scientists are not eligible) and meet established criteria. The awards will be limited to $50,000 per year for 2 years but some may be smaller. The awards are made on the basis of scientific merit, following rigorous scientific review procedures that have been used in for past applications. New Investigator Awards: The DERC Studies Program also administers the Diabetes Investigator Award Program of $25,000 per year to members of the faculty who are making their first entry into diabetes research. These awards are supported to the private DRTP, an endowed fund of the UW to foster diabetes research. The eligibility and evaluation criteria are the same as the P and F program. Fellowships: The P and F program also administers the McAbee Fellowship Program that is also privately funded by the DRTP.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK017047-28
Application #
7550708
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2003-12-01
Budget End
2004-11-30
Support Year
28
Fiscal Year
2004
Total Cost
$303,200
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Han, Seung Jin; Fujimoto, Wilfred Y; Kahn, Steven E et al. (2018) Change in visceral adiposity is an independent predictor of future arterial pulse pressure. J Hypertens 36:299-305
Wacker, Bradley K; Dronadula, Nagadhara; Bi, Lianxiang et al. (2018) Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits. Arterioscler Thromb Vasc Biol 38:206-217
Wander, Pandora L; Hayashi, Tomoshige; Sato, Kyoko Kogawa et al. (2018) Design and validation of a novel estimator of visceral adipose tissue area and comparison to existing adiposity surrogates. J Diabetes Complications 32:1062-1067
Lemaitre, Rozenn N; Yu, Chaoyu; Hoofnagle, Andrew et al. (2018) Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study. Diabetes 67:1663-1672
Xiang, Anny H; Trigo, Enrique; Martinez, Mayra et al. (2018) Impact of Gastric Banding Versus Metformin on ?-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes. Diabetes Care 41:2544-2551
Coleman, Brantley; Topalidou, Irini; Ailion, Michael (2018) Modulation of Gq-Rho Signaling by the ERK MAPK Pathway Controls Locomotion in Caenorhabditis elegans. Genetics 209:523-535
Greenbaum, Carla J; Speake, Cate; Krischer, Jeffrey et al. (2018) Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience. Diabetes 67:1216-1225
Hwang, You Cheol; Fujimoto, Wilfred Y; Kahn, Steven E et al. (2018) Predictors of Incident Type 2 Diabetes Mellitus in Japanese Americans with Normal Fasting Glucose Level. Diabetes Metab J 42:198-206
Rubinow, Katya B; Vaisar, Tomas; Chao, Jing H et al. (2018) Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men. J Clin Lipidol 12:1072-1082
Nagy, Nadine; de la Zerda, Adi; Kaber, Gernot et al. (2018) Hyaluronan content governs tissue stiffness in pancreatic islet inflammation. J Biol Chem 293:567-578

Showing the most recent 10 out of 1296 publications